How the directionality of vesicle traffic is achieved remains an important unanswered question in cell biology. The Sec23p/Sec24p coat complex sorts the fusion machinery (SNAREs) into vesicles as they bud from the endoplasmic reticulum (ER). Vesicle tethering to the Golgi begins when the tethering factor TRAPPI binds to Sec23p. Where the coat is released and how this event relates to membrane fusion is unknown. Here we use a yeast transport assay to demonstrate that an ER-derived vesicle retains its coat until it reaches the Golgi. A Golgi-associated kinase, Hrr25p (CK1d orthologue), then phosphorylates the Sec23p/Sec24p complex. Coat phosphorylation and dephosphorylation are needed for vesicle fusion and budding, respectively. Additionally, we show that Sec23p interacts in a sequential manner with different binding partners, including TRAPPI and Hrr25p, to ensure the directionality of ER-Golgi traffic and prevent the back-fusion of a COPII vesicle with the ER. These events are conserved in mammalian cells.
Membrane fusion is mediated by a highly conserved family of membrane proteins called SNAREs. The pairing of a SNARE on the vesicle (v-SNARE) with its cognate SNARE on the target membrane (t-SNARE) is required for fusion 1 ; however, the same v-SNARE (Sec22p) can act in both anterograde ER-Golgi and retrograde Golgi-ER traffic 2 . This observation implies that factors other than the SNAREs define the direction of membrane flow.
Motifs in the ER-Golgi SNAREs needed for fusion are masked by Sec24p (subunit of the COPII coat) as these fusogens are sorted into ER-derived vesicles 3 . The COPII coat is assembled on the ER when the activated form of the GTPase Sar1p (Sar1p-GTP) recruits the Sec23p/ Sec24p complex by binding to Sec23p, the GTPase-activating protein (GAP) for Sar1p 4 . Polymerization of the coat requires the recruitment of the Sec13p/Sec31p complex (coat outer shell) by the Sec23p/Sec24p complex, which leads to the hydrolysis of GTP on Sar1p and vesicle fission 4 .
The initial interaction of a vesicle with its target membrane is mediated by a class of proteins called tethers that work in conjunction with GTPases of the Rab family 5 . The tethering factor TRAPPI is a multimeric guanine nucleotide exchange factor (GEF) that recruits and activates the Rab GTPase Ypt1p 6 . Previous findings showed that the interaction of TRAPPI with the coat adaptor protein Sec23p is required for vesicle tethering 6 . These studies, however, did not address the question of whether the coat is shed before or after the vesicles bind to the Golgi. Here we show that a Golgi-localized kinase, Hrr25p, displaces purified TRAPPI that is pre-bound to Sec23p and phosphorylates the Sec23p/Sec24p complex. Our findings show that the COPII coat subunit Sec23p interacts in a hierarchical manner with Sar1p, TRAPPI and Hrr25p to ensure the directionality of anterograde membrane flow.
The Golgi inhibits TRAPPI vesicle binding
After COPII vesicles bud from the ER, Sar1p is released from vesicles when GTP is hydrolysed, but the inner and outer shells of the coat are largely retained ( Supplementary Fig. 1) 7 . To define the events that occur after TRAPPI binds to Sec23p, we immobilized TRAPPI on beads and asked when COPII vesicles lose their ability to bind. For these studies, the binding of pro-a-factor-containing vesicles formed with cytosol was considered to be 100% (Fig. 1a ). We observed that vesicles formed in the presence of Golgi lost their ability to bind TRAPPI (Fig. 1a ). Because the binding of vesicles to TRAPPI is mediated by the COPII coat, this experiment indicates that COPII vesicles lose their ability to bind TRAPPI because the Golgi contains a factor that either releases or modifies the coat. To determine whether vesicles must tether to the Golgi to lose their ability to bind to TRAPPI, we formed vesicles with bet3-1 mutant fractions. The bet3-1 mutant, which harbours a mutation in the Bet3p subunit of TRAPPI, is defective in vesicle tethering 6 . The defect in this mutant is partially complemented in vitro by the addition of purified recombinant TRAPPI ( Supplementary Fig. 2a ). Vesicles formed from bet3-1 donor cells and cytosol, with or without Golgi, bound equally well to the TRAPPI-containing beads (Fig. 1a ). These findings indicate that the vesicles must tether to the Golgi to lose their ability to bind to TRAPPI.
COPII vesicle tethering requires TRAPPI, Ypt1p and Uso1p 5,6 . To determine when COPII vesicles lose their ability to bind to TRAPPI, we blocked vesicle tethering and fusion at several different steps in vitro in the presence of Golgi membranes. The pro-a-factor-containing membranes, formed during these blocks, were then tested for their ability to bind to TRAPPI. The transport incompetent vesicles that formed, when Ypt1p function was blocked with anti-Ypt1p antibody, bound efficiently to TRAPPI (Fig. 1b ). Disrupting Ypt1p function should also block the recruitment to vesicles of the long coiled-coil tether Uso1p (yeast orthologue of p115), a Ypt1p effector that links donor and acceptor membranes to each other in vitro 5 . When we formed vesicles with fractions from the uso1-1 mutant, transport incompetent vesicles retained their ability to bind TRAPPI at 27 uC and 17 uC ( Fig. 1c ).
We also blocked fusion in vitro with antibody directed against Sec22p (SNARE) or Sly1p, a Sec1-like protein that binds to SNAREs 8 . In vitro, neutralizing antibody to Sly1p blocks trans-SNARE complex formation 8 . Binding to TRAPPI decreased when vesicles were formed in the presence of anti-Sec22p or anti-Sly1p antibodies (Fig. 1d ). These findings indicate that COPII vesicles lose their ability to bind TRAPPI after Uso1p functions, but before trans-SNARE complex formation. Uso1p does not seem to have a role in vesicle uncoating, as the membrane and soluble pools of Sec23p were unaltered in the uso1-1 mutant in vivo ( Supplementary Fig 3a) and Uso1p/p115 did not release Sec23 from membranes in vitro (see Supplementary Figs 3b, c). Together, these findings indicate that COPII vesicles retain their coat until they reach the Golgi.
Hrr25p phosphoregulates Sec23p/Sec24p
Despite the fact that only 36 6 0.65% of wild-type vesicles uncoat in vitro in the presence of Golgi membranes ( Supplementary Fig. 3d ), 61 6 4% of the vesicles lose their ability to bind to TRAPPI (Fig. 1a ). This observation indicates that the inability of COPII vesicles to bind TRAPPI is not just a consequence of vesicle uncoating. Because the COPII coat inner shell is known to be phosphorylated in mammalian cells 9 , we considered the possibility that phosphorylation of Sec23p may block the ability of COPII vesicles to bind TRAPPI.
To identify a kinase that could phosphorylate Sec23p, we searched the yeast database (http://www.yeastgenome.org) for an essential (Supplementary Fig. 3e ) Golgi-localized kinase. Only one kinase, Hrr25p, was found to have an orthologue (CKId, human orthologue of casein kinase Id) that localizes at the Golgi and ER-Golgi interface in mammalian interphase cells 10 . Inhibiting CKId function was reported to block ER-Golgi traffic 11 , and a mutation that reduced the kinase activity of Hrr25p was shown to suppress the temperature-sensitive COPII vesicle budding defect in the sec12-4 mutant 12 . Although these results implicated Hrr25p/CKId in ER-Golgi traffic, its role in membrane traffic is not well defined.
Hrr25p is known to reside in the nucleus in G1-arrested cells and, like CKId, it is found at the spindle pole body (SPB) in nocodazoletreated (M-phase) cells 10, 13 . When we visualized Hrr25p-RFP (genomic copy tagged with red fluorescent protein) in asynchronously grown cells, however, the majority (.95%) was found on punctate structures that largely colocalize with early (Vrg4p) and late Golgi (Sec7p) markers ( Fig. 2a ). Occasionally, we observed Hrr25p-RFP in the nucleus, at puncta along the nuclear envelope (presumably the SPB), and at the bud neck and cortex, as previously reported 13, 14 . Consistent with its Golgi localization, all of the haemagglutin (HA)tagged Hrr25p co-fractionated with membranes in differential fractionation experiments (Fig. 5a, bottom) .
Both glutathione S-transferase (GST)-tagged Sec23p and GST-Sec24p were phosphorylated by His 6 -tagged Hrr25p ( Fig. 2b and Supplementary Fig. 3f , compare lanes 1 and 2), but not catalytically inactive His 6 -Hrr25p(K38A) in vitro ( Fig. 2b and Supplementary Fig.  3f , lane 3). Phosphorylation in vivo was examined with a conditional allele of hrr25 (ref. 14) . In this mutant, HA-tagged HRR25 degron was placed behind the inducible GAL promoter as the sole copy of the gene. When this strain is grown in galactose, HA-Hrr25p degron is expressed. In the presence of glucose, however, the expression of HA-Hrr25p degron ceases and the protein is rapidly degraded. After 10 h in glucose, when a delay in trafficking of carboxypeptidase Y between the ER-Golgi was observed, most of the Hrr25p degron was degraded (not shown). Lysates prepared from the hrr25 mutant grown with galactose (1Hrr25p) or glucose (2Hrr25p) (Supplementary Fig. 3g ) were precipitated with anti-Sec24p ( Fig. 2c, lanes 1 and 3) , or IgG (Fig. 2c, lanes 2 and 4) . Western blot analysis of the immunoprecipitates with anti-phospho-Ser/Thr antibody revealed that phospho-Sec23p and phospho-Sec24p could only be detected in vivo when Hrr25p was expressed (Fig. 2c, lane 1) .
As Sec23p binds to both TRAPPI and Hrr25p, we determined whether TRAPPI and Hrr25p compete for binding to Sec23p. To do this, the six subunits of the TRAPPI complex were co-expressed in bacteria and purified from bacterial lysates as described previously 6 . When similar amounts of purified His 6 -Hrr25p and TRAPPI were incubated together, Hrr25p effectively competed with TRAPPI for binding to purified GST-Sec23p ( Supplementary Fig. 4a , compare lanes 3-5 to GST controls in lanes 1 and 2). Binding was not dependent on kinase activity, as His 6 -Hrr25p(K38A) bound as efficiently as His 6 -Hrr25p (not shown). Because His 6 -Hrr25p binds with higher affinity to GST-Sec23p (K d 5 0.043 6 0.009 mM; Supplementary Fig.  4b ) than TRAPPI (K d 5 0.63 6 0.15 mM; Supplementary Fig. 4c ), we determined whether it displaces TRAPPI that is pre-bound to GST-Sec23p. Increasing amounts of His 6 -Hrr25p were mixed with GST-Sec23p beads pre-incubated with saturating amounts of TRAPPI ( Fig. 2d ). When the concentration of Hrr25p was increased ( Fig. 2d , lanes 2-5), TRAPPI was released from the beads (Fig. 2d , top, lanes 2-5) into the supernatant (Fig. 2d , bottom, lanes 2-5) as His 6 -Hrr25p bound to GST-Sec23p ( Fig. 2d , middle). These findings show that Hrr25p and TRAPPI compete for binding to Sec23p, and indicate that Hrr25p could displace TRAPPI from Sec23p when COPII vesicles tether to the Golgi. Consistent with the possibility that phosphorylation of the coat blocks the binding of TRAPPI to Sec23p, we observed a decrease in the binding of TRAPPI to GST-Sec23p that contained phosphomimetic mutations at two phosphorylation sites (see later and Supplementary Fig. 5b ).
Conservation of phosphorylation sites in Sec23p
Because Hrr25p phosphorylates Sec23p more efficiently than Sec24p, we focused on Sec23p for subsequent studies. Three Hrr25p phosphorylation sites were identified in Sec23p by mass spectrometry: T555, S742 and T747. Two of these phosphorylated residues, S742 and T747, are conserved from yeast to man and were analysed further ( Fig. 3a, top) . The T747 residue is a known Sar1p contact site, whereas S742 is within a disordered loop in the established structure of Sec23p a, Vesicles formed in vitro with cytosol with or without Golgi were incubated with TRAPPI-containing beads and the precipitated radiolabelled cargo was counted. Cytosol and Golgi were isolated from either wild type (WT) or the bet3-1 mutant. Error bars represent standard deviation (s.d.), N 5 6. In a-d, the per cent transport observed for the total reaction is reported above the bar graphs. b, d, Cytosol and Golgi fractions, derived from wild type, were formed with: anti-Ypt1p (12 mg), anti-Sec22p (12 mg 
RESEARCH ARTICLE
complexed with D23-Sar1p-GTP (PDB accession 2QTV) 15 . Initially, we used computational modelling to predict the consequences of phosphorylation at these sites. We added phosphates on S742 and T747 of Sec23p using Molsoft-ICM software and modified their orientations by several rounds of Monte Carlo optimization. Phosphorylation at T747 presented significant steric clashes with the surface of Sar1p in all possible orientations and was deemed incompatible with Sec23p binding to Sar1p-GTP (Fig. 3a, bottom) . Phosphorylated S742 is also located at the Sec23p-Sar1p interface, but its location within a flexible loop limited our ability to predict consequences (Fig. 3a , bottom) 15 . We found that His 6 -D23-Sar1p-GTPcS bound preferentially to GST-Sec23p ( Supplementary Fig.  5a ), and failed to bind GST-Sec23p harbouring the phosphomimetic S742D, T747E or S742D/T747E (ST-DE) mutations ( Fig. 3b , top, lanes 1-4). Binding of His 6 -Sec24p to GST-Sec23p was unaffected by the phosphomimetic mutations (Fig. 3b, bottom ). If Hrr25p phosphorylates Sec23p at Sar1p contact sites, the addition of His 6 -Hrr25p to the transport assay should disrupt the binding of Sec23p to Sar1p-GTP and inhibit vesicle budding in vitro. When His 6 -Hrr25p was added to the assay at the beginning of the reaction, budding was inhibited as the concentration of His 6 -Hrr25p was increased ( Fig. 3c ). Inhibition was dependent on kinase activity, as no effect was seen with catalytically inactive His 6 -Hrr25p(K38A) ( Fig. 3c ). Consistent with this observation, a yeast strain harbouring the S742D/T747E mutations disrupted vesicle budding and fusion in vitro ( Fig. 3d ) and displayed a severe growth defect at 33 uC (Supplementary Fig. 5c ). The defect in fusion may be the consequence of blocking the cycling of Sec23p on and off membranes (see Fig. 5a ).
Because Hrr25p phosphorylates Sec23p at Sar1p contact sites, and Hrr25p competes with TRAPPI for binding to Sec23p, we wanted to address whether TRAPPI also competes with His 6 -D23-Sar1p-GTPcS for binding to Sec23p. When we incubated a constant amount of His 6 -D23-Sar1p-GTPcS with increasing amounts of TRAPPI, TRAPPI effectively competed with D23-Sar1p-GTPcS for binding to Sec23p (Fig. 4a , top). Similar results were obtained when increasing amounts of His 6 -D23-Sar1p-GTPcS were incubated with a constant amount of TRAPPI (Fig. 4a, bottom) . These results imply that TRAPPI and Sar1p-GTP bind to the same or overlapping site(s) on Sec23p. Consistent with this hypothesis, we found a decrease in the binding of TRAPPI to GST-Sec23p harbouring the S742D/T747E mutations ( Supplementary Fig. 5b ). Together, these findings imply that TRAPPI binds to Sec23p after Sar1p-GTP is released from membranes. This event seems to be conserved in higher eukaryotes (Fig. 4b ), as we could only detect mBet3 on immuno-isolated tagged mammalian COPII vesicles (VSV-G-Myc) formed in vitro with GTP (2Sar1), but not the non-hydrolysable GTP analogue GMP-PNP (1Sar1) or control vesicles that lacked VSV-G-Myc. 
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Loss of Hrr25p activity inhibits fusion
To address the role of Hrr25p phosphorylation in ER-Golgi traffic in vitro, we used the ATP competitive inhibitor IC261, which selectively inhibits the highly conserved kinase domain of CK1d 11, 16 . As seen in Fig. 4c , increasing concentrations of IC261 inhibited fusion. To address whether IC261 inhibits membrane fusion or vesicle tethering, we formed vesicles in the presence of Golgi with or without inhibitor, and then fractionated the reaction product on a sucrose velocity gradient that separates free vesicles ( Supplementary Fig. 2b, top) from vesicles that are bound to the Golgi ( Supplementary Fig. 2b, bottom) . Subsequently, each fraction was treated with ConA Sepharose to precipitate radiolabelled pro-a-factor. Most of the vesicles bound to the Golgi in the presence of IC261, indicating that the inhibitor largely blocks fusion and not tethering ( Supplementary Fig. 2b, bottom) .
Interestingly, when the transport assay was performed with concentrations of IC261 that inhibited fusion, a stimulation in vesicle budding was observed (Fig. 4d ). This finding indicates that dephosphorylation is needed for budding and is consistent with an earlier report showing that phosphorylated mammalian Sec24 cannot form a pre-budding complex 9 . A prediction of this result is that loss of kinase activity should stimulate cargo export in vivo (see later) and could explain why a kinase loss-of-function mutation was identified as a suppressor of the sec12-4 mutant 12 . We were unable to address the role of CK1d in vitro because the mammalian COPII vesicle tethering assay did not work robustly at the lower ATP concentrations needed to test the inhibitor.
To address whether phosphorylation and dephosphorylation alter the distribution of Sec23p on membranes in vivo, a differential fractionation experiment was performed with the conditional hrr25 mutant after growth in galactose-or glucose-containing medium. The SNARE Bos1p served as a membrane marker for these studies. This analysis revealed the presence of a soluble pool of Sec23p when HA-Hrr25p was expressed (Fig. 5a, lanes 1-3) . In the absence of HA-Hrr25p, however, all of the Sec23p was membrane-bound (Fig. 5a,  lanes 4-6) . Although Hrr25p activity seems to have a role in releasing Sec23p from membranes in vivo, we found it was not sufficient to uncoat the vesicles in the absence of Golgi membranes in vitro (data not shown).
In mammalian cells, COPII vesicles fuse to each other or with COPI (Golgi) vesicles to form a pre-Golgi compartment that matures into a 
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Golgi 17 . To address the role of CKId in vivo, we accumulated tsO45 VSV-G-GFP in the ER of NRK cells at 40 uC and then shifted the cells in the presence and absence of IC261 to 15 uC, a temperature that selectively slows traffic at the pre-Golgi compartment step 18 . In the presence of inhibitor, the pre-Golgi (marked by rbet1) but not early Golgi (marked by gpp130) was markedly dispersed (Fig. 5b) . Consistent with the observation that inhibiting CK1d function stimulates COPII vesicle budding and blocks fusion, VSV-G-GFP was more rapidly depleted from the ER and concentrated at peripheral sites of the pre-Golgi compartment (Fig. 5b, c) , the site where COPII vesicles fuse. The VSV-G-GFP remained at the peripheral sites in the IC261-treated cells and failed to concentrate in the peri-Golgi region (Fig. 5d, e ). Together, these findings imply that the events we describe here are conserved in higher cells.
Discussion
The CKI family of kinases represents a unique group of highly conserved serine/threonine kinases that regulate a variety of cellular processes, including membrane traffic 11, 12 . Here we report that Sec23p, a component of the inner shell of the COPII coat, sequentially interacts with three different binding partners, Sar1p, TRAPPI and Hrr25p, to control the direction of ER-Golgi traffic. These interactions define three different stages in vesicle traffic: budding, tethering and a prefusion step. As Sar1p is required for fission 19, 20 , our findings imply that TRAPPI can only bind to Sec23p after vesicle fission and the release of Sar1p from membranes ( Fig. 6, (1) ). This ensures that COPII vesicle tethering is only initiated after a vesicle buds from the ER. Subsequently, TRAPPI activates Ypt1p on the vesicle (Fig. 6, (2) ). Genetic studies and a kinetic analysis of GEF activity have revealed that TRAPPI is more than a GEF 21 . GEFs typically release Rabs soon after they activate them. TRAPPI, however, forms a relatively stable ternary complex (TRAPPI-Ypt1p-nucleotide) with the Rab 21 , implying that it is also a Ypt1p effector. In parallel, the pool of Ypt1p-GTP that is released from TRAPPI can then recruit the long coiled-coil tether Uso1p (Fig. 6,  (3) ). When Uso1p bends, the vesicle comes into proximity with the Golgi, triggering the release of TRAPPI from the vesicle (Fig. 6, (3) ). Hrr25p, which concentrates on the Golgi in yeast, could facilitate this release. Phosphorylation of the Sec23p/Sec24p complex by Hrr25p may be required, but is not sufficient for COPII vesicle uncoating. Another kinase could also be involved in this event as Sec31p, a known phosphoprotein 22 , seems to be phosphorylated by a different kinase 12 and Hrr25p cannot uncoat COPII vesicles in vitro.
Fusogenic SNARE motifs that bind to the coat must be unmasked before trans-SNARE complex formation can proceed at the target ARTICLE RESEARCH membrane 3 . Phosphorylation of Sec24p by Hrr25p/CKId could have a role in disengaging the SNAREs from the coat at the Golgi. As the COPII coat only acts in anterograde traffic 4 , the compartmentalization of a kinase that regulates membrane fusion at the Golgi, ensures an ER-Golgi v-SNARE will only pair with its cognate t-SNARE. The directionality imposed by this cycle also prevents the back-fusion of a COPII vesicle with the ER. The findings we report here describe a new role for Hrr25p/CKId that may extend to other CKI family members and coats.
METHODS SUMMARY
Yeast COPII vesicles were formed in vitro with donor cells, cytosol, with or without Golgi for 90 min at 20 uC or 27 uC or 120 min at 17 uC as described previously 6 . The vesicle binding assays were performed as described previously 6 . Additional information is provided in Methods.
Protein and antibody purifications were performed as before 6 . Mass spectrometry analysis, in vitro bindings assays, kinase and immunoprecipitation assays, microscopy, the construction of phosphomimetic mutations and all studies with mammalian cells are described in Methods.
ER Golgi
Cargo Ypt1p-GTP TRAPPI 
RESEARCH ARTICLE
METHODS Yeast in vitro transport and vesicle binding assays. For the vesicle binding assays, the permeabilized cells were pelleted after the in vitro transport reaction as described previously 6 . The conditions used to remove the cells did not pellet slowly sedimenting membranes that contain radiolabelled cargo. The supernatant was transferred to a new tube that contained 40 ml of a 50% slurry of TRAPPIcontaining beads 6 . The final volume of the reaction was adjusted to 500 ml with TBPS (25 mM HEPES (pH 7.2), 115 mM potassium acetate, 2.5 mM magnesium acetate, 250 mM sorbitol plus protease inhibitors) and the reaction was incubated for 2 h at 4 uC. The beads were washed three times with 750 ml of TBPS and counted. The counts from a no vesicle control reaction (reaction with apyrase with or without Golgi) were subtracted as background. The binding of vesicles formed with cytosol was considered to be 100%, and the amount of binding (with or without Golgi) was adjusted to equal Concanavalin A (ConA) counts (equal vesicles). Two-stage transport assays were also performed. Vesicles were formed in the absence of Golgi, the cells were pelleted and an equal number of vesicles were incubated with or without Golgi before the binding assay was performed.
For reactions with IC261, the ATP concentration of the 103 ATP stock was lowered to 1.7 mM ATP. For the vesicle tethering assay, free vesicles were separated from vesicles that bound to the Golgi on a sucrose velocity gradient as described previously 6 . In vitro kinase assay. Purified GST, GST-Sec23p and GST-Sec24p (5 mg), immobilized on beads, were incubated with 250 ng of His 6 -Hrr25p or catalytically inactive His 6 -Hrr25p(K38A) or no kinase in kinase assay buffer (50 mM HEPES pH 7.4, 2 mM EDTA, 10 mM MgCl 2 , 1 mM DTT, 5 mM cold ATP, 2.5 mCi cP 32 -ATP, 100 mM sodium orthovanadate, 10 mM sodium fluoride, 10 mM sodium pyrophosphate and protease inhibitors) for 1 h at 30 uC. The beads were washed twice with 13 PBS and eluted in 25 ml of sample buffer by heating to 100 uC for 5 min. The samples were analysed by autoradiography. Nucleotide loading of His 6 -D23-Sar1p. His 6 -D23-Sar1p was loaded with the desired nucleotide (GDP or GTPcS) overnight at 4 uC in the following buffer: 20 mM HEPES pH 7.2, 150 mM NaCl, 1 mM MgCl 2 with 0.1 mM of nucleotide. In vitro binding assays with recombinant proteins. For the binding experiments with the phosphomimetic mutations in GST-Sec23p, equimolar amounts (0.1 mM) of GST, GST-Sec23p beads with or without phosphomimetic mutations were incubated with either 5-10 nM of His 6 -D23-Sar1p-GTPcS (nucleotide was loaded as described earlier) or 10 nM of purified TRAPPI 6 in binding buffer I (25 mM HEPES pH 7.2, 150 mM NaCl, 2% Triton X-100, 1 mM DTT, 2 mM EDTA, 0.5 mM MgCl 2 and protease inhibitors) for 3-4 h at 4 uC. The beads were washed three times with binding buffer I and eluted in 25 ml of sample buffer by heating to 100 uC for 5 min.
For the TRAPPI displacement assay, 0.5 mM of TRAPPI was incubated overnight at 4 uC in binding buffer I with 0.1 mM of GST-Sec23p or GST. The next day, the beads were washed three times in binding buffer I and resuspended in binding buffer II (25 mM HEPES pH 7.2, 150 mM NaCl, 0.1% Triton X-100, 1 mM DTT, 2 mM EDTA, 0.5 mM MgCl 2 and protease inhibitors). Increasing amounts (0-0.25 mM) of purified His 6 -Hrr25p were added to the reactions and incubated for 4 h at 4 uC. Subsequently, the supernatants were aliquoted into fresh tubes and heated in sample buffer to 100 uC for 5 min. The beads were washed three times with binding buffer I and eluted as described earlier.
For the competition assay between Hrr25p and TRAPPI, 0.3 mM of GST-Sec23p or GST beads were incubated with 0.25 mM of purified TRAPPI and/or 0.15 mM of His 6 -Hrr25p in binding buffer I for 3-4 h at 4 uC. For the competition assay between Sar1p and TRAPPI, 0.1 mM of GST-Sec23p or GST beads were incubated with 10 nM of purified His 6 -D23Sar1p-GTPcS with increasing concentrations (0-50 nM) of TRAPPI as above. For the reciprocal experiment, GST fusion proteins were incubated with 10 nM of TRAPPI and increasing concentrations (0-50 nM) of His 6 -D23Sar1p-GTPcS. The beads were then washed three times with binding buffer I and eluted as above. The molarity of TRAPPI was calculated based on the amount of Trs33p in the complex. Yeast immunofluorescence microscopy. Cells expressing Vrg4p-GFP or Sec7p-GFP and Hrr25p-RFP were grown to an OD 599 nm of 0.5-1.5 in YPD medium. One to two OD 599 nm units were pelleted and resuspended in 25 ml of YPD medium. Cells were examined with a Carl Zeiss Observer Z.1 spinning-disk confocal fluorescence microscope using DIC, GFP, or RFP filters with a 3100 oil-immersion objective. Images were captured with a Zeiss AxioCam MRm and analysed using AxioVision Rel. 4.7 software. At least 300 puncta (and 100 cells) were examined in three separate experiments that were used to calculate the s.d. shown in Fig. 2a . Growth conditions for the hrr25 mutant. SFNY1941 (MATa ura3-52 lys2-801 ade2-101 trpD63 his3-D200 leu2-D1hrr25D::loxP-kanMX-loxP pKK204(2m pGAL-3HA-HRR25 degron ) was grown in YP-Raf-Gal (2% Raffinose, 0.5% Galactose) medium to OD 599 nm 5 1-2. A total of 500 OD 599 nm units of cells were pelleted under sterile conditions and shifted to either YP-Raf-Gal or YPD (YP 1 2% glucose) medium for 10 h. Differential centrifugation experiment. A total of 100 OD 599 nm units of cells were pelleted, resuspended in 2 ml of spheroplast buffer (1.4 M sorbitol, 100 mM sodium phosphate pH 7.5, 0.35% 2-mercaptoethanol and 0.5 mg ml 21 zymolyase) and incubated for 30 min at 37 uC. The spheroplasted cells were then divided into four 0.5 ml aliquots and centrifuged over a 1 ml sorbitol cushion (1.7 M sorbitol, 100 mM HEPES pH 7.2) for 5 min at 3,800g at 4 uC in a microfuge. The supernatant was removed and the four pellets were resuspended in 1 ml of lysis buffer (100 mM HEPES pH 7.2, 1 mM EGTA, 0.2 mM DTT, 1 mM PMSF and protease inhibitors) and lysed using a Dounce homogenizer. The lysate was centrifuged for 2 min at 500g at 4 uC in a microfuge and the supernatant was transferred to a new tube. An aliquot of this fraction (100 ml) was mixed with 50 ml of 33 sample buffer (total fraction, T) and heated at 100 uC for 5 min, while the remaining portion (600 ml) was centrifuged for 90 min at 190,000g at 4 uC in a Beckman SW55 Ti rotor. The lipid layer was removed and 100 ml of the supernatant (S) was mixed with 50 ml of 33 sample buffer and heated at 100 uC for 5 min. The pellet (P) was resuspended in 500 ml of lysis buffer and 100 ml was mixed with 50 ml of 33 sample buffer and heated at 100 uC for 5 min. Immunoprecipitation assay to detect phosphorylation. SFNY1941 was grown as described earlier and whole-cell lysates (10 mg) were immunoprecipitated with anti-Sec24 antibody. The immunoprecipitates were then immunoblotted with anti-phospho-Ser/Thr (BD Biosciences, 1:500 dilution), anti-Sec24 (1:1,000 dilution) and anti-Sec23 antibodies (1:1,000 dilution). Mass spectrometry analysis. In vitro phosphorylated GST-Sec23p was trypsindigested and subjected to liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) analysis as described previously 23 . Generation of Sec23p phosphomimetic mutations. The phosphomimetic mutations (S742D, T747E and S742D/T747E) in GST-Sec23p were generated by the two-step PCR method for site-directed mutagenesis using pPE124 (ref. 24) as the template. Mutations in pRS414-SEC23(S742D/T747E) were generated on pCF364 (ref. 25) using the QuikChange Site-directed mutagenesis kit (Agilent Technologies). All constructs were verified by sequencing. Analysis of mBet3 and mSec23 on mammalian COPII vesicles. A detailed description of the generation, immunoisolation and immunoblotting of COPII transport intermediates derived from semi-intact normal rat kidney (NRK) cells is described elsewhere 17 . Briefly, a VSV-G-Myc construct was introduced by electroporation and its expression in the ER was amplified using vaccinia virus VTF-7 at 41 uC. After permeabilization, the VSV-G-Myc-expressing cells or control untransfected NRK cells were suspended in a vesicle budding cocktail and incubated at 32 uC for 30 min. Subsequently, the donor cells were removed by sedimentation. For the p115 experiment, the supernatant (which contains released COPII vesicles) was then incubated with purified full-length His 6 -p115 (ref. 26) for 60 min at 32 uC. The p115 preparation was functional in tests of interactions with ER-Golgi SNAREs (not shown). The suspension of transport intermediates was then subjected to immunoisolation using anti-Myc antibody. Proteins were eluted from the beads using 0.1 M glycine pH 2.5, neutralized, concentrated, and analysed on a 4-20% gradient SDS polyacrylamide gel followed by western blot analysis. To quantitate the abundance of mBet3 and mSec23 on the isolated vesicles and to normalize to vesicle yield, we divided the band intensity by the signal for the cargo marker VSV-G-Myc and syntaxin 5 for each lane. The cargo-normalized mBet3 and mSec23 signals were then expressed as a percentage relative to the GTP condition. GMP-PNP was used at 100 mM concentration. Analysing ER-Golgi traffic in vivo in the presence of IC261. NRK cells were electroporated with a plasmid encoding VSV-G ts045-GFP, plated on glass coverslips in 6-well plates and incubated overnight at 40 uC. Ten minutes before the temperature shift, 100 mM IC261 (solubilized in DMSO) or DMSO was added to the medium at 40 uC. After 10 min, the coverslips were either fixed in 4% paraformaldehyde for 30 min, or shifted to 15 uC medium containing IC261 or DMSO. At 15 uC, VSV-G-GFP can leave the ER, but accumulates in swollen peripheral ER-Golgi interface structures that only slowly move towards the Golgi area 27 . The 15 uC treatment makes ER exit, pre-Golgi assembly and transport to the Golgi more resolvable. Coverslips were fixed after 30 or 60 min at 15 uC.
After fixation, coverslips were treated twice for 10 min with 0.1 M glycine and then the samples were permeabilized in BSA/goat serum blocking solution containing 0.35% saponin. All subsequent antibody incubations and washes were carried out in blocking solution containing saponin. Primary antibody incubations included the anti-rbet1 mouse monoclonal antibody 16G6 (ref. 28 ) and a rabbit polyclonal antisera against gpp130 (Covance Research Products). 16G6 is known to label rbet1 more intensely when the antigen accumulates at peripheral sites 29 . Secondary antibodies were goat anti-mouse-cy3 and goat anti-rabbit-cy5. DAPI was also included during the secondary antibody incubation. After extensive ARTICLE RESEARCH washing, the coverslips were mounted in Slow-fade Gold mounting medium (Invitrogen) and imaged using the wide-field microscope and instrumentation methods described before 29 . Briefly, each field of cells were captured in four colours (GFP, cy3, cy5 and DAPI) at 21 focal planes through the sample. Image stacks were then deconvolved using the Huygens algorithm (Scientific Volume Imaging). Maximum intensity projections from five consecutive image planes were used for quantification and display.
To quantify the transfer from the ER to pre-Golgi structures, each set of images was opened as an image stack in the Openlab program (Improvision). The extracellular background was subtracted from each image, and then a roughly square region of interest (ROI) that abutted the nucleus and extended approximately three-quarters of the distance to the edge of the cell was hand-drawn. This ROI was chosen such that it constituted a region of cytoplasm completely free of any Golgi labelling. The rbet1 image was used to define a pre-Golgi mask within this larger ROI using an intensity threshold of 4-63 the rbet1 labelling background. The pre-Golgi mask was then subtracted from the original ROI to create an ER mask. The pre-Golgi and ER mask were sequentially applied to the VSV-G-GFP image to determine the average maximum intensity of cargo spots in the pre-Golgi compartment, and the average intensity of cargo in the ER, respectively. The ratio of these two parameters, average maximum intensity in the pre-Golgi compartment divided by average intensity in the ER, was determined for each of the twenty randomly sampled images from each condition.
To quantify the concentration of pre-Golgi structures near the Golgi, a Golgi mask was derived from the gpp130 image using an intensity threshold of 10% of maximum intensity for the Golgi area of interest. A total punctate cargo mask was derived from the VSV-G-GFP image by choosing an intensity threshold for each cell sample such that a faint punctate spot would be captured in the mask but residual diffuse ER labelling would not. This cargo mask was then superimposed on the Golgi mask and all cargo-containing objects that did not partially or completely overlap with a Golgi object were deleted from the cargo mask. This peri-Golgi cargo mask, as well as the original total cargo mask were sequentially applied to the VSV-G-GFP image to determine the total intensity of cargo spots in the peri-Golgi region and in the whole cell, respectively. The ratio of these two parameters, total intensity of cargo spots in the peri-Golgi region divided by total intensity of cargo spots in the cell, was determined for each of the 20 randomly sampled images analysed for each condition.
For both quantifications, the average raw ratio for DMSO-treated cells from a given experiment was defined as 100% and each individual ratio value from that experiment was expressed relative to 100%. This normalization step allowed combination of quantifications from independent experiments to produce the values for Fig. 5c and e. All experiments in the manuscript were performed at least three times or more on separate days.
